Research to improve people's health

0
0
0
s2smodern

The IDIAPJGol presents the results of 2 projects at the IRISCAT - COVID19 Conference

The General Directorate of Research and Innovation of the Department of Health, called a year ago with 4 million euros to finance research and innovation projects for the prevention and treatment of COVID-19. Only 19 were the selected projects, 2 of which are projects led by IDIAPJGol. These projects are the study on the immune response in health professionals infected with SARS-CoV-2 and the project to develop predictive models of complications.

pexels edward jenner 4031710 1

0
0
0
s2smodern

The Biblioteca de Catalunya subsidizes formation on bibliographic resources

Profesionales sanitarios de la Atención Primaria podrán acceder a estos seminarios web sobre recursos bibliográficos de la biblioteca digital de Salud. El acceso a estos cursos es subvencionado.

pexels skitterphoto 442420

0
0
0
s2smodern

The IDIAP Jordi Gol ethics committee approves the pilot test to open Girona

The test is waiting for the evolution of Easter infections

girona 1141814 1280

0
0
0
s2smodern

An article from the IDIAPJGol project Eira is the most read of the month in the Health Gazette

The editor of Gaceta Sanitaria Joan Carles March has interviewed IDIAP researcher Anna Berenguera together with Montse Gil-Girbau and Kika Pujol, the three authors of the article 'Theoretical Models of Health Promotion in Habitual Practice in Primary Health Care'

2021 04 14 17 55 05 12 Promoción de Salud Atención Primaria YouTube

0
0
0
s2smodern

Do international research from the CAP

Primary Care also focuses on health research. Through the IDIAPJGol, today 1,500 family and community medicine and nursing professionals participate in research projects that will be decisive in improving health in the next decade.

44790087124 684260e188 k

Foto: Ariadna Creus i Àngel García / Banc d'imatges Infermeres COIB

0
0
0
s2smodern

IDIAPJGol promotes E-SPERANZA COVID: an independent clinical trial on persistent Covid-19

The E-SPERANZA COVID is an independent clinical trial that will evaluate the effectiveness of Montelukast, an already marketed drug used in people with asthma. The trial, an independent study, has been submitted to several calls for funding, and also opts for external funding. The clinical trial is directed by the family doctor of the Center d'Atenció Primària El Pla de Sant Feliu de Llobregat of the Direcció d'Atenció Primària Costa Ponent de l'Institut Català de la Salut, and researcher at the IDIAPJGol Francisco Mera Cordero.

pexels oles kanebckuu 127873